A decade of systems biology

Annual Review of Cell and Developmental Biology

Volumn 26, Issue , 2010, Pages 721-744

  Chuang, Han Yu ^a,b   Hofree, Matan ^c   Ideker, Trey ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

biomarkers; cell fate; developmental biology; epistasis; genetic interaction; genome wide association study (GWAS); genome wide measurements; high throughput technology; models; networks

Indexed keywords

BIOLOGICAL MARKER;

CANCER THERAPY; CELL FATE; CELL MATURATION; COMPUTER PROGRAM; GENE IDENTIFICATION; GENE INTERACTION; GENETIC DISORDER; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; SYSTEMS BIOLOGY; ANIMAL; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENOMICS; INSTRUMENTATION; METHODOLOGY;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MODELS, BIOLOGICAL; SYSTEMS BIOLOGY;

EID: 78049413383     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-cellbio-100109-104122     Document Type: Review

References (124)

1. Adler AS, Lin M, Horlings H, Nuyten DSA, van de Vijver MJ, Chang HY. 2006. Genetic regulators oflarge-scale transcriptional signatures in cancer. Nat. Genet. 38:421-30
2. Amit I, Garber M, Chevrier N, Leite AP, Donner Y, et al. 2009. Unbiased reconstruction of a mammaliantranscriptional network mediating pathogen responses. Science 326:257-63
3. Anastassiou D. 2007. Computational analysis of the synergy among multiple interacting genes. Mol. Syst. Biol.3:83
4. Andrianantoandro E, Basu S, Karig DK, Weiss R. 2006. Synthetic biology: new engineering rules for anemerging discipline. Mol. Syst. Biol. 2:2006.0028
5. Asyali MH, Colak D, Demirkaya O, Inan MS. 2006. Gene expression profile classification: a review. Curr.Bioinforma. 1:55-73
6. Avery L, Wasserman S. 1992. Ordering gene function: the interpretation of epistasis in regulatory hierarchies.Trends Genet. 8:312-16
7. Bakal C, Linding R, Llense F, Heffern E, Martin-Blanco E, et al. 2008. Phosphorylation networks regulatingJNK activity in diverse genetic backgrounds. Science 322:453-56
8. Bandyopadhyay S, Kelley R, Krogan NJ, Ideker T. 2008. Functional maps of protein complexes from quantitative genetic interaction data. PLoS Computat. Biol. 4:e1000065
9. Benfey PN, Mitchell-Olds T. 2008. From genotype to phenotype: systems biology meets natural variation. Science 320:495-97
10. Benner SA, Sismour AM. 2005. Synthetic biology. Nat. Rev. 6:533-43
11. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. 2006. A bivalent chromatin structure markskey developmental genes in embryonic stem cells. Cell 125:315-26
12. Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB. 2008. Unraveling epigenetic regulation in embryonicstem cells. Cell Stem Cell 2:123-34
13. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. 2006. Oncogenic pathway signatures in human cancersas a guide to targeted therapies. Nature 439:353-57
14. Bommi-Reddy A, Almeciga I, Sawyer J, Geisen C, Li W, et al. 2008. Kinase requirements in human cells:III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proc. Natl. Acad. Sci. USA 105:16484-89
15. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. 2005. Core transcriptional regulatory circuitryin human embryonic stem cells. Cell 122:947-56
16. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441:349-53
17. Breslin T, Krogh M, Peterson C, Troein C. 2005. Signal transduction pathway profiling of individual tumorsamples. BMC Bioinformatics 6:163
18. Brown KR,OtasekD,AliM,McGuffinMJ,XieW,etal.2009.NAViGaTOR:Network Analysis,Visualizationand Graphing Toronto. Bioinformatics 25:3327-29
19. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. 2005. A network-based analysis of systemicinflammation in humans. Nature 437:1032-37
20. Cheang MCU, van de Rijn M, Nielsen TO. 2008. Gene expression profiling of breast cancer. Annu. Rev. Pathol. Mech. Dis. 3:67-97
21. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. 2008. Integration of external signaling pathways with the coretranscriptional network in embryonic stem cells. Cell 133:1106-17
22. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. 2007. Network-based classification of breast cancer metastasis. Mol. Syst. Biol. 3:140
23. Cline M, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. 2007. Integration of biological networks andgene expression data using Cytoscape. Nat. Protoc. 2:2366-82
24. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. 2008. Tcf3 is an integral component of the coreregulatory circuitry of embryonic stem cells. Genes Dev. 22:746-55
25. Collins SR, Schuldiner M, Krogan NJ, Weissman JS. 2006. A strategy for extracting and analyzing large-scalequantitative epistatic interaction data. Genome Biol. 7:R63
26. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, et al. 2010. The genetic landscape of a cell. Science327:425-31
27. Culverhouse R, Suarez B, Lin J, Reich T. 2002. A perspective on epistasis: limits of models displaying no maineffect. Am. J. Hum. Genet. 70:461-71
28. Ding L, Paszkowski-Rogacz M, Nitzsche A, Slabicki MM, Heninger AK, et al. 2009. A genome-scale RNAiscreen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell StemCell 4:403-15
29. Dixon SJ, Costanzo M, Baryshnikova A, Andrews B, Boone C. 2009. Systematic mapping of genetic interactionnetworks. Annu. Rev. Genet. 43:601-25
30. Dixon SJ, Fedyshyn Y, Koh JLY, Prasad TSK, Chahwan C, et al. 2008. Significant conservation of synthetic lethal genetic interaction networks between distantly related eukaryotes. Proc. Natl. Acad. Sci. USA105:16653-58
31. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. 2003. MAPPFinder: usingGene Ontology and GenMAPP to create a global gene-expression profile from microarray data. GenomeBiol. 4:R7.
32. Donnelly P. 2008. Progress and challenges in genome-wide association studies in humans. Nature 456:728-31
33. Draghici S, Khatri P, Martins RP, Ostermeier GC, Krawetz SA. 2003. Global functional profiling of geneexpression. Genomics 81:98-104
34. Efroni S, Schaefer CF, Buetow KH. 2007. Identification of key processes underlying cancer phenotypes usingbiologic pathway analysis. PLoS One 2:e425
35. Ein-Dor L, Kela I, Getz G, Givol D, Domany E. 2005. Outcome signature genes in breast cancer: is there aunique set? Bioinformatics 21:171-78
36. Ergün A, Lawrence C, Kohanski M, Brennan T, Collins J. 2007. A network biology approach to prostatecancer. Mol. Syst. Biol. 3:82
37. Farmer H, McCabe N, Lord C, Tutt A, Johnson D, et al. 2005. Targeting the DNA repair defect in BRCAmutant cells as a therapeutic strategy. Nature 434:917-21
38. Fouse SD, Shen Y, Pellegrini M, Cole S, Meissner A, et al. 2008. Promoter CpG methylation contributes to EScell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2:160-69
39. Franke L, Bakel HV, Fokkens L, de Jong ED, Egmont-Petersen M, Wijmenga C. 2006. Reconstruction of afunctional human gene network, with an application for prioritizing positional candidate genes. Am. J.Hum. Genet. 78:1011-25
40. Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H. 2008. CellDesigner 3.5: a versatilemodeling tool for biochemical networks. Proc. IEEE 96:1254-65
41. Glinsky GV, Berezovska O, Glinskii AB. 2005. Microarray analysis identifies a death-from-cancer signaturepredicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115:1503-21
42. Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabási A-L. 2007. The human disease network. Proc. Natl. Acad. Sci. USA 104:8685-90
43. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcriptioninitiation at most promoters in human cells. Cell 130:77-88
44. Guo Z, Zhang T, Li X, Wang Q, Xu J, et al. 2005. Towards precise classification of cancers based on robustgene functional expression profiles. BMC Bioinformatics 6:58
45. Hannum G, Srivas R, Guénolé A, van Attikum H, Krogan N, Kerr K. 2009. Genome-wide association datareveal a global map of genetic interactions. PLoS Genet. 5:e1000782
46. Harding A. 1983. Classification of the hereditary ataxias and paraplegias. Lancet 321:1151-55
47. Hillenmeyer M, Fung E, Wildenhain J, Pierce S, Hoon S, et al. 2008. The chemical genomic portrait of yeast:uncovering a phenotype for all genes. Science 320:362-65
48. Hirschhorn JN, Daly MJ. 2005. Genome-wide association studies for common diseases and complex traits. Nat. Rev. 6:95-108
49. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ. 2009. A genome-wide RNAi screen identifies a newtranscriptional module required for self-renewal. Genes Dev. 23:837-48
50. Hu Z, Snitkin E, Delisi C. 2008. VisANT: an integrative framework for networks in systems biology. BriefBioinform. 9:317-25
51. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, et al. 2003. The systems biology markup language(SBML): a medium for representation and exchange of biochemical network models. Bioinformatics19:524-31
52. Ideker T, Galitski T, Hood L. 2001. A new approach to decoding life: systems biology. Annu. Rev. GenomicsHum. Genet. 2:343-72
53. Ingenuity. Ingenuity Pathways Analysis Software. http://www.ingenuity. com/
54. Jiang J,Chan YS, Loh YH, Cai J, Tong GQ, et al. 2008. A core Klf circuitry regulates self-renewalofembryonicstem cells. Nat. Cell Biol. 10:353-60
55. Johnson R, Teh CH, Kunarso G, Wong KY, Srinivasan G, et al. 2008. REST regulates distinct transcriptionalnetworks in embryonic and neural stem cells. PLoS Biol. 6:e256
56. Kidder BL, Yang J, Palmer S. 2008. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stemcells. PLoS One 3:e3932
57. Kim J, Chu J, Shen X, Wang J, Orkin SH. 2008. An extended transcriptional network for pluripotency ofembryonic stem cells. Cell 132:1049-61
58. Kitano H. 2002. Systems biology: a brief overview. Science 295:1662-64
59. Kitano H, Funahashi A, Matsuoka Y, Oda K. 2005. Using process diagrams for the graphical representationof biological networks. Nat. Biotechnol. 23:961-66
60. Lagarkova MA, Volchkov PY, Lyakisheva AV, Philonenko ES, Kiselev SL. 2006. Diverse epigenetic profileof novel human embryonic stem cell lines. Cell Cycle 5:416-20
61. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, et al. 2007. A human phenome-interactomenetwork of protein complexes implicated in genetic disorders. Nat. Biotech. 25:309-16
62. Lee E, Chuang H-Y, Kim J-W, Ideker T, Lee D. 2008. Inferring pathway activity toward precise diseaseclassification. PLoS Comput. Biol. 4:e1000217
63. LehnerB, Crombie C, Tischler J,Fortunato A, Fraser AG. 2006. Systematic mapping of genetic interactions inCaenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 38:896-903
64. Linding R, Jensen LJ, Ostheimer GJ, van Vugt MATM, Jørgensen C, et al. 2007. Systematic discovery of invivo phosphorylation networks. Cell 129:1415-26
65. Liu X, Huang J, Chen T, Wang Y, Xin S, et al. 2008. Yamanaka factors critically regulate the developmentalsignaling network in mouse embryonic stem cells. Cell Res. 18:1177-89
66. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al. 2006. The Oct4 and Nanog transcription networkregulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38:431-40
67. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, et al. 2009. A genome-wide RNAi screen identifiesmultiple synthetic lethal interactions with the Ras oncogene. Cell 137:835-48
68. Ma X, Lee H, Wang L, Sun F. 2007. CGI: a new approach for prioritizing genes by combining gene expressionand protein-protein interaction data. Bioinformatics 23:215-21
69. MacArthur BD, Ma'ayan A, Lemischka IR. 2009. Systems biology of stem cell fate and cellular reprogramming. Nat. Rev. Mol. Cell Biol. 10:672-81
70. Maher B. 2008. Personal genomes: the case of the missing heritability. Nature 456:18-21
71. Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, et al. 2008a. A systems biology approach to predictionof oncogenes and molecular perturbation targets in B-cell lymphomas. Mol. Syst. Biol. 4:169
72. Mani R, St. Onge RP, Hartman JL, Giaever G, Roth FP. 2008b. Defining genetic interaction. Proc. Natl. Acad. Sci. USA 105:3461-66
73. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, et al. 2008. Connecting microRNA genes tothe core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-33
74. Mendes-Pereira AM, Martin SA, Brough R, McCarthy A, Taylor JR, et al. 2009. Synthetic lethal targeting ofPTEN mutant cells with PARP inhibitors. EMBO Mol. Med. 1:315-22
75. Mathur D, Danford TW, Boyer LA, Young RA, Gifford DK, Jaenisch R. 2008. Analysis of the mouse embryonic stem cell regulatory networks obtained by ChIP-chip and ChIP-PET. Genome Biol. 9:R126
76. Michod D, Widmann C. 2007. DNA-damage sensitizers: potential new therapeutical tools to improvechemotherapy. Crit. Rev. Oncol. Hematol. 63:160-71
77. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. 2007. Genome-wide maps of chromatin state inpluripotent and lineage-committed cells. Nature 448:553-60
78. Moore J. 2003. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56:73-82
79. Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, et al. 2010. Mechanism of radiosensitization bythe Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologousrecombinational DNA repair. Cancer Res. 70(12):4972-81
80. Muller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, et al. 2008. Regulatory networks define phenotypicclasses of human stem cell lines. Nature 455:401-5
81. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, et al. 2007. Genome-wide analysis ofgenetic alterations in acute lymphoblastic leukaemia. Nature 446:758-64
82. Myers RH. 2004. Huntington's disease genetics. NeuroRx 1:255-62
83. Nibbe RK, Markowitz S, Myeroff L, Ewing R, Chance MR. 2009. Discovery and scoring of protein interactionsubnetworks discriminative of late stage human colon cancer. Mol. Cell Proteomics 8:827-45
84. Nikitin A, Egorov S, Daraselia N, Mazo I. 2003. Pathway studio-the analysis and navigation of molecularnetworks. Bioinformatics 19:2155-57
85. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. 2005. A novel method for generation of signature networks asbiomarkers from complex high throughput data. Toxicol. Lett. 158:20-29
86. Ooi SL, Shoemaker DD, Boeke JD. 2003. DNA helicase gene interaction network defined using syntheticlethality analyzed by microarray. Nat. Genet. 35:277-86
87. Oti M, Brunner H. 2007. The modular nature of genetic diseases. Clin. Genet. 71:1-11
88. Oti M, Snel B, Huynen MA, Brunner HG. 2006. Predicting disease genes using protein-protein interactions. J. Med. Genet. 43:691-98
89. Pavlidis P, Qin J, Arango V, Mann JJ, Sibille E. 2004. Using the gene ontology for microarray data mining:a comparison of methods and application to age effects in human prefrontal cortex. Neurochem. Res.29:1213-22
90. Peng G, Luo L, Siu H, Zhu Y, Hu P, et al. 2009. Gene and pathway-based second-wave analysis of genome-wide association studies. Eur. J. Hum. Genet. 18:111-17
91. Pu S, Ronen K, Vlasblom J, Greenblatt J, Wodak SJ. 2008. Local coherence in genetic interaction patternsreveals prevalent functional versatility. Bioinformatics 24:2376-83
92. Quackenbush J. 2006. Microarray analysis and tumor classification. New Engl. J. Med. 354:2463-72
93. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic V, et al. 2010. An atlas of combinatorial transcriptionalregulation in mouse and man. Cell 140(5):744-52
94. Roguev A, Bandyopadhyay S, Zofall M, Zhang K, Fischer T, et al. 2008. Conservation and rewiring offunctional modules revealed by an epistasis map in fission yeast. Science 322:405-10
95. Roguev A, Wiren M, Weissman JS, Krogan NJ. 2007. High-throughput genetic interaction mapping in thefission yeast Schizosaccharomyces pombe. Nat. Meth. 4:861-66
96. Rommens J, Iannuzzi M, Kerem B, Drumm M, Melmer G, et al. 1989. Identification of the cystic fibrosisgene: chromosome walking and jumping. Science 245:1059-65
97. Scholl C, Fröhling S, Dunn I, Schinzel A, Barbie D, et al. 2009. Synthetic lethal interaction between oncogenicKRAS dependency and STK33 suppression in human cancer cells. Cell 137:821-34
98. Schuldiner M, Collins SR, Thompson NJ, Denic V, Bhamidipati A, et al. 2005. Exploration of the function andorganization of the yeast early secretory pathway through an epistatic miniarray profile. Cell 123:507-19
99. Shannon P, Markiel A, Ozier O, Baliga N, Wang J, et al. 2003. Cytoscape: a software environment forintegrated models of biomolecular interaction networks. Genome Res. 13:2498-504
100. ShenY,Chow J,WangZ,FanG.2006. Abnormal CpG island methylation occurs duringinvitro differentiationof human embryonic stem cells. Hum. Mol. Genet. 15:2623-35
101. Sotiriou C, Piccart MJ. 2007. Taking gene-expression profiling to the clinic: when will molecular signaturesbecome relevant to patient care? Nat. Rev. 7:545-53
102. Spooncer E, Brouard N, Nilsson SK, Williams B, Liu MC, et al. 2008. Developmental fate determination andmarker discovery in hematopoietic stem cell biology using proteomic fingerprinting. Mol. Cell Proteomics7:573-81
103. St Onge RP, Mani R, Oh J, Proctor M, Fung E, et al. 2007. Systematic pathway analysis using high-resolutionfitness profiling of combinatorial gene deletions. Nat. Genet. 39:199-206
104. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. 2005. Gene set enrichment analysis: aknowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA102:15545-50
105. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, Franken NA, Haveman J, et al. 2006. Analysis of geneexpression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoSMed. 3:e422
106. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, et al. 2009. Dynamic modularity in proteininteraction networks predicts breast cancer outcome. Nat. Biotechnol. 27:199-204
107. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. 2005. Discovering statistically significantpathways in expression profiling studies. Proc. Natl. Acad. Sci. USA 102:13544-49
108. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. 2005. Recurrent fusion of TMPRSS2and ETS transcription factor genes in prostate cancer. Science 310:644-48
109. Tong AHY, Evangelista M, Parsons AB, Xu H, Bader GD, et al. 2001. Systematic genetic analysis with orderedarrays of yeast deletion mutants. Science 294:2364-68
110. Tong AHY, Lesage G, Bader GD, Ding H, Xu H, et al. 2004. Global mapping of the yeast genetic interactionnetwork. Science 303:808-13
111. Torkamani A, Topol EJ, Schork NJ. 2008. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92:265-72
112. Tuck DP, Kluger HM, Kluger Y. 2006. Characterizing disease states from topological properties of transcrip-tional regulatory networks. BMC Bioinforma. 7:236
113. Ulitsky I, Karp RM, Shamir R. 2008a. Detecting disease-specific dysregulated pathways via analysis of clinicalexpression profiles. Lect. Notes Comput. Sci. 4955:347
114. Ulitsky I, Shamir R. 2007. Identification of functional modules using network topology and high-throughputdata. BMC Syst. Biol. 1:8
115. Ulitsky I, Shlomi T, Kupiec M, Shamir R. 2008b. From E-MAPs to module maps: dissecting quantitativegenetic interactions using physical interactions. Mol. Syst. Biol. 4:209
116. Vert JP, Kanehisa M. 2003. Extracting active pathways from gene expression data. Bioinformatics 19(Suppl.2):ii238-44
117. Wang J, Rao S, Chu J, Shen X, Levasseur DN, et al. 2006. A protein interaction network for pluripotency ofembryonic stem cells. Nature 444:364-68
118. Wang K, Li M, Bucan M. 2007. Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet. 81:1278-83
119. Wang K, Saito M, Bisikirska BC, Alvarez MJ, Lim WK, et al. 2009. Genome-wide identification of post-translational modulators of transcription factor activity in human B cells. Nat. Biotech. 27:829-37
120. Wei Z, Li H. 2007. A Markov random field model for network-based analysis of genomic data. Bioinformatics 23: 1537-44
121. Yang WS, Stockwell B. 2008. Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol. 9:R92
122. Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, et al. 2006. Combined cDNA array comparativegenomic hybridization and serial analysis of gene expression analysis of breast tumor progression. CancerRes. 66:4065-78
123. Yeo S, Jeong S, Kim J, Han JS, Han YM, Kang YK. 2007. Characterization of DNA methylation changein stem cell marker genes during differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 359:536-42
124. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, et al. 2008. An oncogenomics-based in vivo RNAiscreen identifies tumor suppressors in liver cancer. 135:852-64